Dunn P P J, Day S, Williams S, Bendukidze N
DNA Reference Laboratory, National Blood Service, Southmead Road, Bristol BS10 5ND, UK. paul.dunn@nzblood. co.nz
Tissue Antigens. 2005 Aug;66(2):99-106. doi: 10.1111/j.1399-0039.2005.00445.x.
Sequencing-based typing (SBT) human leukocyte antigen (HLA) class I and II genes should examine entire exon sequences where polymorphisms lie. Primers for the amplification of complete exons therefore anneal in introns and their design relies on accurate intron sequences being available. We decided to develop a SBT method for HLA-DQB1 using amplification primers which anneal in introns 1 and 2, yet the amount of intron sequence data previously available in databases was sparse. Therefore, we undertook a systematic sequencing of introns 1 and 2 using DNA from cell lines homozygous for DQB1. This study confirmed an earlier report that the non-coding regions of this gene are the most polymorphic seen in the human genome. Intron sequences within an allele group were largely identical, the exceptions being DQB10301 differing from other DQB103 allele groups and DQB10601 differing from all other DQB106 alleles. A retroviral Alu element, related to the AluYa5a2 subfamily, was identified uniquely inserted in intron 2 of DQB1*02 alleles. For the typing approach, six amplification primers were designed based on conserved allele group sequences covering all of the HLA DQB antigens, and two sequencing primers were also designed which anneal in intron 2. This method has proved to be very robust and has been used as part of a referral DNA sequencing service for a number of years.
基于测序的分型(SBT)人类白细胞抗原(HLA)I类和II类基因应检测多态性所在的整个外显子序列。因此,用于扩增完整外显子的引物在内含子中退火,其设计依赖于可获得准确的内含子序列。我们决定开发一种用于HLA - DQB1的SBT方法,使用在内含子1和2中退火的扩增引物,但数据库中先前可用的内含子序列数据很少。因此,我们使用DQB1纯合细胞系的DNA对内含子1和2进行了系统测序。这项研究证实了早期的一份报告,即该基因的非编码区是人类基因组中多态性最高的区域。一个等位基因组内的内含子序列基本相同,例外情况是DQB10301与其他DQB103等位基因组不同,DQB10601与所有其他DQB106等位基因不同。在DQB1*02等位基因的内含子2中独特地插入了一个与AluYa5a2亚家族相关的逆转录病毒Alu元件。对于分型方法,基于覆盖所有HLA DQB抗原的保守等位基因组序列设计了六种扩增引物,还设计了两种在内含子2中退火的测序引物。这种方法已被证明非常可靠,并已作为转诊DNA测序服务的一部分使用了数年。